Paper30218445
Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.
Okhuijsen-Pfeifer C and 6 others. Acta Psychiatr Scand, 2018. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis. Papers, record 30218445. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30218445
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Clozapine | Major topic |
| Outcome Assessment, Health Care | Major topic |
| Schizophrenia | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30240545 | Clozapine as an early-stage treatment. | https://conductscience.org/library/papers/30240545 |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 374401 | Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. | J Clin Psychiatry | 1979 | https://conductscience.org/library/papers/374401 | PubMed |
| 2 | 769027 | An example of European multicenter trials: multispectral analysis of clozapine. | Psychopharmacol Bull | 1976 | https://conductscience.org/library/papers/769027 | PubMed |
| 3 | 20332509 | CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. | BMJ | 2010 | https://conductscience.org/library/papers/20332509 | PubMed |
| 4 | 21972272 | Clozapine: dangerous orphan or neglected friend? | Br J Psychiatry | 2011 | https://conductscience.org/library/papers/21972272 | PubMed |
| 5 | 24937002 | Clozapine-induced concordant agranulocytosis in monozygotic twins. | Int J Psychiatry Clin Pract | 2001 | https://conductscience.org/library/papers/24937002 | PubMed |
| 6 | 16782758 | Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. | Schizophr Bull | 2006 | https://conductscience.org/library/papers/16782758 | PubMed |
| 7 | 21292928 | Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial. | Br J Psychiatry | 2011 | https://conductscience.org/library/papers/21292928 | PubMed |
| 8 | 30218445 | Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis. | Acta Psychiatr Scand | 2018 | https://conductscience.org/library/papers/30218445 | PubMed |
| 9 | 16414249 | Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia. | Eur Psychiatry | 2006 | https://conductscience.org/library/papers/16414249 | PubMed |
| 10 | 770512 | Clozapine in the treatment of newly admitted schizophrenic patients. A pilot study. | J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/770512 | PubMed |
| 11 | 24927201 | Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis. | Int J Psychiatry Clin Pract | 1999 | https://conductscience.org/library/papers/24927201 | PubMed |
| 12 | 10796289 | Clozapine versus typical neuroleptic medication for schizophrenia. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/10796289 | PubMed |
| 13 | 24402218 | Is disorganized schizophrenia a predictor of treatment resistance? Evidence from an observational study. | Braz J Psychiatry | 2013 | https://conductscience.org/library/papers/24402218 | PubMed |
| 14 | 9384923 | Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients. | Harv Rev Psychiatry | 1995 | https://conductscience.org/library/papers/9384923 | PubMed |
| 15 | 8685657 | Clozapine eligibility among state hospital patients. | Schizophr Bull | 1996 | https://conductscience.org/library/papers/8685657 | PubMed |
| 16 | 10435416 | Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report. | Psychopharmacology (Berl) | 1999 | https://conductscience.org/library/papers/10435416 | PubMed |
| 17 | 9345668 | Mortality in current and former users of clozapine. | Epidemiology | 1997 | https://conductscience.org/library/papers/9345668 | PubMed |
| 18 | 24465255 | Successful Early Clozapine Trial in the Treatment of First-episode Schizophrenia: A Case Report. | Clin Psychopharmacol Neurosci | 2013 | https://conductscience.org/library/papers/24465255 | PubMed |
| 19 | 22937265 | Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study. | Schizophr Res Treatment | 2011 | https://conductscience.org/library/papers/22937265 | PubMed |
| 20 | 28750580 | Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia. | Am J Psychiatry | 2017 | https://conductscience.org/library/papers/28750580 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959242 | Redox compromise as an early, modifiable entry point in schizophrenia: a staging framework for early intervention. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42959242 | PubMed |
| 42936159 | Genetic Susceptibility to Clozapine-Induced Agranulocytosis/Neutropenia Across Ethnicities: Results From a New Cohort of Turkish and Other Caucasian Participants, and Meta-Analysis. | Schizophr Bull Open | 2020 | https://conductscience.org/library/papers/42936159 | PubMed |
| 42136059 | Underprescription of Clozapine: A Narrative Review Regarding 'Clozaphobia'. | Hum Psychopharmacol | 2026 | https://conductscience.org/library/papers/42136059 | PubMed |
| 42004310 | Mental health nurses' knowledge and attitudes toward clozapine management protocols challenges and implications for clinical practice: A narrative review. | AIMS Public Health | 2026 | https://conductscience.org/library/papers/42004310 | PubMed |
| 41613742 | A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS Era. | Focus (Am Psychiatr Publ) | 2025 | https://conductscience.org/library/papers/41613742 | PubMed |
| 40824996 | Declines and pronounced state-level variation in clozapine use among Medicare patients. | PLoS One | 2025 | https://conductscience.org/library/papers/40824996 | PubMed |
| 40746110 | Randomised controlled trial of clozapine in resistant schizophrenia and schizoaffective disorder. | J Psychopharmacol | 2025 | https://conductscience.org/library/papers/40746110 | PubMed |
| 39954151 | Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review. | Metab Brain Dis | 2025 | https://conductscience.org/library/papers/39954151 | PubMed |
| 39848730 | Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study. | Lancet Psychiatry | 2025 | https://conductscience.org/library/papers/39848730 | PubMed |
| 39333502 | Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts. | Transl Psychiatry | 2024 | https://conductscience.org/library/papers/39333502 | PubMed |
| 38764552 | Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance. | ACG Case Rep J | 2024 | https://conductscience.org/library/papers/38764552 | PubMed |
| 38319320 | [Management of treatment resistance-Treatment-resistant schizophrenia]. | Nervenarzt | 2024 | https://conductscience.org/library/papers/38319320 | PubMed |
| 38312438 | Impact of COVID-19 quarantines on clozapine-induced constipation: Experience of utilizing a clozapine-induced constipation protocol at a state forensic psychiatric facility. | Ment Health Clin | 2024 | https://conductscience.org/library/papers/38312438 | PubMed |
| 38275523 | Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug. | Brain Sci | 2024 | https://conductscience.org/library/papers/38275523 | PubMed |
| 37665047 | Clozapine and Sweet's syndrome: case report. | BJPsych Open | 2023 | https://conductscience.org/library/papers/37665047 | PubMed |
| 37506738 | Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial. | Pharmacopsychiatry | 2023 | https://conductscience.org/library/papers/37506738 | PubMed |
| 37318540 | Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder. | Psychopharmacology (Berl) | 2023 | https://conductscience.org/library/papers/37318540 | PubMed |
| 37238731 | Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine. | Biomolecules | 2023 | https://conductscience.org/library/papers/37238731 | PubMed |
| 36943247 | Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. | Schizophr Bull | 2023 | https://conductscience.org/library/papers/36943247 | PubMed |
| 36580106 | Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis. | Eur Arch Psychiatry Clin Neurosci | 2023 | https://conductscience.org/library/papers/36580106 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30218445
GET https://conductscience.org/api/papers/v1/30218445/references?page=2